Growth Metrics

Merck (MRK) Treasury Shares (2016 - 2026)

Merck has reported Treasury Shares over the past 18 years, most recently at $63.7 billion for Q1 2026.

  • Quarterly Treasury Shares rose 7.32% to $63.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $63.7 billion through Mar 2026, up 7.32% year-over-year, with the annual reading at $63.0 billion for FY2025, 8.05% up from the prior year.
  • Treasury Shares was $1.1 billion for Q1 2026 at Merck, roughly flat from $1.1 billion in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.1 billion in Q1 2026 and troughed at $4.0 million in Q3 2023.
  • The 5-year median for Treasury Shares is $1.0 billion (2022), against an average of $934.0 million.
  • Year-over-year, Treasury Shares fell 1.09% in 2022 and then grew 8.05% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $56.5 billion in 2022, then grew by 1.7% to $57.4 billion in 2023, then grew by 1.48% to $58.3 billion in 2024, then grew by 8.05% to $63.0 billion in 2025, then grew by 1.19% to $63.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Treasury Shares are $63.7 billion (Q1 2026), $63.0 billion (Q4 2025), and $61.8 billion (Q3 2025).